RENEW-SHCS: Safety and Immunogenicity of a Recombinant HIV Env Protein Vaccine in ARV-treated Adults Living With HIV in the SHCS
Clinical trial NCT07769983 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07769983
- Sponsor
- University of Zurich
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-27
- Primary completion
- 2028-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.